Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NL-OMON59301Phase 3Completed
Phase 3, open-label, single-arm trial of fentanyl, sponsored by Leiden University Medical Center. Primary endpoint: Arterial PCO2 in recovery phase. Started Mar 2024; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NL-OMON59301.